Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,940,000 | 7,588,000 | 8,229,000 | 12,851,000 | 10,027,000 |
| Marketable Securities | 12,149,000 | 17,922,000 | 3,666,000 | 1,756,000 | 101,000 |
| Receivables | 3,327,000 | 3,851,000 | 4,514,000 | 5,854,000 | 4,635,000 |
| Inventories | 814,000 | 801,000 | 1,587,000 | 1,955,000 | 1,386,000 |
| Income taxes - deferred | N/A | N/A | N/A | 828,000 | 508,000 |
| TOTAL | $35,836,000 | $31,823,000 | $19,588,000 | $24,762,000 | $17,714,000 |
| Non-Current Assets | |||||
| PPE Net | 4,006,000 | 3,295,000 | 2,865,000 | 2,276,000 | 1,674,000 |
| Investments And Advances | 1,423,000 | 11,184,000 | 20,485,000 | 11,601,000 | 1,598,000 |
| Intangibles | 19,855,000 | 21,259,000 | 10,143,000 | 11,419,000 | 12,245,000 |
| Other Non-Current Assets | 2,555,000 | 2,722,000 | 3,896,000 | 1,658,000 | 1,433,000 |
| TOTAL | $27,839,000 | $38,460,000 | $37,389,000 | $26,954,000 | $16,950,000 |
| Total Assets | $63,675,000 | $70,283,000 | $56,977,000 | $51,716,000 | $34,664,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,748,000 | 2,747,000 | N/A | 982,000 | 483,000 |
| Accounts payable and accrued liabilities | 790,000 | 814,000 | 1,206,000 | 1,178,000 | 955,000 |
| Accrued Expenses | 3,928,000 | 4,704,000 | 5,021,000 | 4,118,000 | 2,316,000 |
| TOTAL | $10,605,000 | $11,635,000 | $9,218,000 | $9,890,000 | $5,761,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,614,000 | 31,353,000 | 26,643,000 | 21,468,000 | 12,507,000 |
| Deferred Revenues | N/A | N/A | N/A | 440,000 | 134,000 |
| aiOther Non-Current Liabilities | 5,917,000 | 6,778,000 | 1,766,000 | 1,247,000 | 619,000 |
| TOTAL | $31,536,000 | $38,147,000 | $28,396,000 | $22,713,000 | $13,084,000 |
| Total Liabilities | $42,141,000 | $49,782,000 | $37,614,000 | $32,603,000 | $18,845,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,275,511 | 1,309,968 | 1,307,067 | 1,366,846 | 1,489,402 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 2,000 |
| Retained earnings | 19,024,000 | 19,012,000 | 18,154,000 | 18,001,000 | 12,732,000 |
| Other shareholders' equity | 227,000 | 224,000 | 754,000 | 667,000 | 694,000 |
| TOTAL | $21,534,000 | $20,501,000 | $19,363,000 | $19,113,000 | $15,819,000 |
| Total Liabilities And Equity | $63,675,000 | $70,283,000 | $56,977,000 | $51,716,000 | $34,664,000 |